The Recall Desk
CriticalFDA (Drugs)·D-1340-2014·Announced 2014-05-28

XZEN Platinum Recalled for Undeclared Sildenafil and Tadalafil

Schindele Enterprises is recalling XZEN Platinum dietary supplements because they contain undeclared sildenafil and tadalafil, which were marketed without FDA approval.

What this means for you

Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.

Our severity reasoning: The agency classification is FDA Class I, which is defined as a situation where use of or exposure to a violative product may cause serious adverse health consequences or death. Per the rubric, FDA Class I recalls are assigned a score of 5.

Plain-English summary

Schindele Enterprises dba Midwest Wholesale is recalling 89 blister packs of XZEN Platinum, 750 mg, distributed by XZEN in Los Angeles, California. The product is identified by Lot 130520PL with an expiration date of 05/31/2017.

The recall was initiated because the dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil. These ingredients are prescription drugs that were marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).

The affected products were distributed to Pennsylvania, Illinois, Texas, Iowa, Georgia, Connecticut, Florida, California, Louisiana, New York, Maryland, Nevada, and Wisconsin. Consumers should stop using the product and contact the recalling firm for instructions on disposal or return.

The recalled product

Product
XZEN PLATINUM, 750 mg, Distributed by: XZEN, Los Angeles, CA.
Affected units
89

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot 130520PL Exp. 05/31/2017

Distribution

Distributed in 13 states:

Part of a larger recall action

This product is one of 7 recalled by Schindele Enterprises dba Midwest Wholesale under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 7 products in this recall →